KMT2A and leukemia: Transformation of MLL-AF9 fusion gene into mouse ES cells demonstrated that non-malignant expansion of myeloid precursors is the first stage of MLL-AF9-mediated leukemia followed by accumulation of malignant cells in bone marrow and other tissue [4].